Wall Street Zen Upgrades Addus HomeCare (NASDAQ:ADUS) to "Buy"

Addus HomeCare (NASDAQ:ADUS - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Sunday.

Other equities analysts have also issued research reports about the stock. JMP Securities reiterated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a report on Friday, June 20th. Macquarie reaffirmed an "outperform" rating and set a $133.00 target price on shares of Addus HomeCare in a research report on Tuesday, June 10th. Finally, Stephens reissued an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. Seven analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $142.57.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS opened at $115.12 on Friday. The company has a market cap of $2.12 billion, a P/E ratio of 25.99, a PEG ratio of 1.63 and a beta of 0.81. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74. Addus HomeCare has a one year low of $88.96 and a one year high of $136.72. The business's 50-day simple moving average is $110.24 and its 200 day simple moving average is $111.66.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The company had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. During the same quarter last year, the company earned $1.21 earnings per share. Addus HomeCare's revenue for the quarter was up 20.3% on a year-over-year basis. On average, sell-side analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the transaction, the executive vice president now directly owns 7,796 shares in the company, valued at $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 4.60% of the company's stock.

Institutional Trading of Addus HomeCare

Institutional investors and hedge funds have recently modified their holdings of the business. Natixis boosted its holdings in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after buying an additional 132 shares during the period. Smartleaf Asset Management LLC lifted its holdings in Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after acquiring an additional 214 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S acquired a new position in Addus HomeCare in the first quarter valued at approximately $41,000. Parkside Financial Bank & Trust boosted its stake in Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after acquiring an additional 148 shares during the period. Finally, Meeder Asset Management Inc. bought a new position in shares of Addus HomeCare during the fourth quarter valued at approximately $77,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.